{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:54:57Z","timestamp":1790373297510,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T10:23:58Z","timestamp":1553509438000},"page":"2401-2407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses"],"prefix":"10.1016","volume":"37","author":[{"given":"Jerilyn R.","family":"Izac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Camire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Earnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica E.","family":"Embers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-318X","authenticated-orcid":false,"given":"Rebecca A.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Breitschwerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2019.02.007_b0005","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10482-014-0164-x","volume":"105","author":"Adeolu","year":"2014","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"13","key":"10.1016\/j.vaccine.2019.02.007_b0010","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM198303313081302","article-title":"Spirochetes isolated from the blood of two patients with Lyme disease","volume":"308","author":"Benach","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.02.007_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198303313081301","article-title":"The spirochetal etiology of Lyme disease","volume":"308","author":"Steere","year":"1983","journal-title":"N Engl J Med"},{"issue":"4552","key":"10.1016\/j.vaccine.2019.02.007_b0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jme\/tjv237","article-title":"County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States","volume":"53","author":"Eisen","year":"2016","journal-title":"J Med Entomol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.007_b0030","doi-asserted-by":"crossref","first-page":"194","DOI":"10.14745\/ccdr.v43i10a01","article-title":"Surveillance for Lyme disease in Canada: 2009\u20132015","volume":"43","author":"Gasmi","year":"2017","journal-title":"Can Commun Dis Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2019.02.007_b0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2015.1854","article-title":"Surveillance for borrelia burgdorferi in ixodes ticks and small rodents in British Columbia","volume":"15","author":"Morshed","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.007_b0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1645\/GE-2874.1","article-title":"Widespread dispersal of Borrelia burgdorferi-infected ticks collected from songbirds across Canada","volume":"98","author":"Scott","year":"2012","journal-title":"J Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10493-016-0068-8","article-title":"Host, habitat and climate preferences of Ixodes angustus (Acari: Ixodidae) and infection with Borrelia burgdorferi and Anaplasma phagocytophilum in California, USA","volume":"70","author":"Stephenson","year":"2016","journal-title":"Exp Appl Acarol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jvim.15042","article-title":"Borrelia burgdorferi infection and lyme disease in North American horses: A consensus statement","volume":"32","author":"Divers","year":"2018","journal-title":"J Vet Intern Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.007_b0055","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/jvim.13973","article-title":"Seroprevalence of borrelia burgdorferi in horses presented for coggins testing in southwest virginia and change in positive test results approximately 1 year later","volume":"30","author":"Funk","year":"2016","journal-title":"J Vet Intern Med"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.007_b0060","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3201\/eid2109.150417","article-title":"Incidence of clinician-diagnosed lyme disease, United States, 2005\u20132010","volume":"21","author":"Nelson","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.02.007_b0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMp1807870","article-title":"Tickborne diseases - confronting a growing threat","volume":"379","author":"Paules","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.007_b0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/jvim.15085","article-title":"ACVIM consensus update on Lyme borreliosis in dogs and cats","volume":"32","author":"Littman","year":"2018","journal-title":"J Vet Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.007_b0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/JCM.38.1.382-388.2000","article-title":"Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice","volume":"38","author":"Schwan","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2019.02.007_b0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1042\/bst0310108","article-title":"Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi","volume":"31","author":"Schwan","year":"2003","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.007_b0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/153036601750137705","article-title":"OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks","volume":"1","author":"Tsao","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.007_b0090","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1073\/pnas.89.12.5418","article-title":"Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice","volume":"89","author":"Fikrig","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.007_b0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/emboj\/20.5.971","article-title":"Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi","volume":"20","author":"Kumaran","year":"2001","journal-title":"Embo J"},{"issue":"13","key":"10.1016\/j.vaccine.2019.02.007_b0100","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1074\/jbc.M010062200","article-title":"Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi","volume":"276","author":"Eicken","year":"2001","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.007_b0105","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1128\/CVI.00409-06","article-title":"OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine","volume":"14","author":"Earnhart","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.007_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/genetics\/151.1.15","article-title":"Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto","volume":"151","author":"Wang","year":"1999","journal-title":"Genetics"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.007_b0115","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1128\/iai.64.6.2234-2239.1996","article-title":"Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC","volume":"64","author":"Gilmore","year":"1996","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.007_b0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF01710681","article-title":"Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection","volume":"20","author":"Preac-Mursic","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2019.02.007_b0125","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/iai.65.11.4661-4667.1997","article-title":"Borrelia burgdorferi strain-specific OspC mediated immunity in mice","volume":"65","author":"Bockenstedt","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.02.007_b0130","first-page":"24(1)","article-title":"Protective immunogenicity of homodimeric borrelia burgdorferi outer surface protein C","author":"Edmondson","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.007_b0135","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/CVI.00099-06","article-title":"Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development","volume":"13","author":"Buckles","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.007_b0140","doi-asserted-by":"crossref","first-page":"e67445","DOI":"10.1371\/journal.pone.0067445","article-title":"Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi","volume":"8","author":"Baum","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.007_b0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2006.07.052","article-title":"Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains","volume":"25","author":"Earnhart","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.007_b0150","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1128\/IAI.73.12.7869-7877.2005","article-title":"Demonstration of OspC type diversity in invasive human Lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response","volume":"73","author":"Earnhart","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.007_b0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4161\/hv.4661","article-title":"An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences","volume":"3","author":"Earnhart","year":"2007","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2019.02.007_b0160","first-page":"SAB-00193","article-title":"Technical bulletin: VANGUARD crLyme: Chimeric recombinant vaccien technology for broad-spectrum protection against canine Lyme disease","author":"Ball","year":"2016","journal-title":"Zoetis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/2049-632X.12119","article-title":"Assessment of the potential contribution of the highly conserved C-terminal motif (C10) of Borrelia burgdorferi outer surface protein C in transmission and infectivity","volume":"70","author":"Earnhart","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2019.02.007_b0170","first-page":"573","article-title":"C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease","volume":"10","author":"Jobe","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.02.007_b0175","first-page":"746","article-title":"Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters","volume":"12","author":"Lovrich","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.007_b0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/CVI.00431-06","article-title":"Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease","volume":"14","author":"Lovrich","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CVI.00373-08","article-title":"Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease","volume":"16","author":"LaFleur","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.007_b0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1086\/515382","article-title":"Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi","volume":"178","author":"Rousselle","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.007_b0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tvjl.2016.11.001","article-title":"Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development","volume":"218","author":"Oliver","year":"2016","journal-title":"Vet J"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0200","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2958.2010.07103.x","article-title":"Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment","volume":"76","author":"Earnhart","year":"2010","journal-title":"Mol Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.007_b0205","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/IAI.01542-15","article-title":"The treponema denticola FhbB protein is a dominant early antigen that elicits FhbB variant-specific antibodies that block factor h binding and cleavage by dentilisin","volume":"84","author":"Miller","year":"2016","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.007_b0210","doi-asserted-by":"crossref","first-page":"e0189071","DOI":"10.1371\/journal.pone.0189071","article-title":"Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding","volume":"12","author":"Embers","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.007_b0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CVI.00685-15","article-title":"Five-antigen fluorescent bead-based assay for diagnosis of lyme disease","volume":"23","author":"Embers","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2019.02.007_b0220","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.vaccine.2017.04.079","article-title":"Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development","volume":"35","author":"Izac","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.007_b0225","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1074\/jbc.M112.339721","article-title":"Structure of factor H binding protein B (FhbB) of the periopathogen, Treponema denticola: Insights into the progression of periodontal disease","volume":"287","author":"Miller","year":"2012","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.vaccine.2019.02.007_b0230","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1128\/AEM.01704-09","article-title":"Population structure of the lyme borreliosis spirochete Borrelia burgdorferi in the western black-legged tick (Ixodes pacificus) in Northern California","volume":"75","author":"Girard","year":"2009","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.007_b0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/genetics\/160.3.833","article-title":"Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the Northeastern United States","volume":"160","author":"Qiu","year":"2002","journal-title":"Genetics"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.007_b0240","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tvjl.2013.07.019","article-title":"Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design","volume":"198","author":"Rhodes","year":"2013","journal-title":"Vet J"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.007_b0245","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1128\/IAI.67.10.5463-5469.1999","article-title":"Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope","volume":"67","author":"Gilmore","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.02.007_b0250","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fcimb.2017.00131","article-title":"Investigation of ospC expression variation among Borrelia burgdorferi strains","volume":"7","author":"Xiang","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.007_b0255","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/IAI.01725-06","article-title":"Rapid clearance of lyme disease spirochetes lacking OspC from skin","volume":"75","author":"Tilly","year":"2007","journal-title":"Infect Immun"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2019.02.007_b0260","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1107\/S0907444900017546","article-title":"Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein C (OspC)","volume":"57","author":"Kumaran","year":"2001","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.007_b0265","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1128\/IAI.66.9.4073-4079.1998","article-title":"The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif","volume":"66","author":"Mathiesen","year":"1998","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2019.02.007_b0270","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1016\/j.vaccine.2006.12.051","article-title":"Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens","volume":"25","author":"Earnhart","year":"2007","journal-title":"Vaccine"},{"issue":"6660","key":"10.1016\/j.vaccine.2019.02.007_b0275","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/37551","article-title":"Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi","volume":"390","author":"Fraser","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.vaccine.2019.02.007_b0280","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1086\/343043","article-title":"Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain","volume":"186","author":"Wang","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:29Z","timestamp":1759401089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":56,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X19301902"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}